Rajesh Chopra

Rajesh Chopra is a distinguished biomedical scientist currently serving as Chief Scientific Officer at Prologue Medicines since April 2025. Prior to this role, Rajesh held the position of Venture Partner and Head of Oncology at ATP (Apple Tree Partners) from April 2020 to April 2025. Rajesh's extensive experience in the field of oncology includes significant academic and leadership roles, such as Professor of Translational Cancer Discovery and Director of Cancer Research at The Institute of Cancer Research and Royal Marsden Hospital from January 2016 to October 2021. Rajesh's previous positions include Corporate Vice President of Translational Research at Celgene, Medical Science Director at Astrazeneca, and Director of Haematological Oncology and Stem Cell Transplantation at Christie Hospital. Rajesh began the career trajectory as a Group Leader at the Paterson Institute while serving as a Senior Lecturer at The University of Manchester. The educational background includes a BSc, MBBS, FRCP, FRCPath, and PhD in Medicine, Cell and Molecular Biology from UCL, completed between 1979 and 1985.